IP Library Granted Patent US 8,993,551
Granted Patent B2
US 8,993,551 · App. 12/715,515 · Granted Mar 31, 2015

Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof

Inventors: Alan Ferguson (Calgary, CA); John Charles Davidson (Calgary, CA)
A61K31/202A61K31/557A61K31/05A61K31/56A61K31/575
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,993,551
App. No.
12/715,515
Granted
Mar 31, 2015
Kind
B2
Abstract

A nutritional supplement composed of phytosterols, anti-oxidants, and other complexes, including essential fatty acids, amino acids, peptides, proline rich polypeptides and digestive enzymes is described. The nutritional supplement may be used by individuals suffering from or at risk of developing immune system diseases; breast cancer, colon and prostate cancer; HIV infection; high cholesterol; or enlarged prostate. In the preferred form, the invention comprises phytosterols and antioxidants, together with essential fatty acids derived from amino acids, short chain peptides, proline rich polypeptides and digestive enzymes, and a microcellulose filler.

Claims (12)

1. A method of treating an allergy comprising administering to an individual in need of such treatment an effective amount of a composition consisting of:

300 mg beta-sitosterols;

50 mg essential fatty acid complexes;

20 mg proanthocyanidins, flavonoids and polyphenols; and

30 mg micro-cellulose filler.

2. The method according to claim 1 wherein the individual is in need of a reduction in basophil count and the effective amount is sufficient to reduce basophil count in said individual.

3. A method of treating an allergy in an individual in need of such treatment comprising administering to the individual an amount of a composition consisting of:

300 mg beta-sitosterols;

50 mg essential fatty acid complexes;

20 mg proanthocyanidins, flavonoids and polyphenols; and

30 mg micro-cellulose filler;

said amount being sufficient to reduce basophil count in said individual compared to a control.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2018
From: FERGUSSON, ALAN, MR
To: DAVIDSON, JOHN CHARLES, MR
Reel/Frame 047295/0452 →
Priority Claims (1)
CA 2407429 · Oct 16, 2002 · national
Continuity (4)
Division 11361982 · Feb 27, 2006
Continuation In Part 11106446 · Apr 15, 2005
Continuation In Part PCTCA0301451 · Sep 24, 2003
Related Publication 20110059930A1 · Mar 10, 2011